首页> 外文期刊>Experimental and therapeutic medicine >miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells
【24h】

miR-155 inhibitor reduces the proliferation and migration in osteosarcoma MG-63 cells

机译:miR-155抑制剂可减少骨肉瘤MG-63细胞的增殖和迁移

获取原文
获取原文并翻译 | 示例
           

摘要

As the most common malignant primary bone tumor in childhood, osteosarcoma (OS) maintains a high recurrence, despite the significant improvements in the overall survival rate of high-grade OS patients during the recent decades. Therefore, a novel therapy strategy is required for OS treatment. Recently, various microRNAs (miRNAs or miRs) have been confirmed as deregulated in OS, and the miR-155 dysregulation in OS has been discovered by the microarray analysis. In the present study, the regulation of miR-155 on the OS cell proliferation, migration and invasion on the MG-63 cells was explored in vitro. The miR-155 mimics were found to promote cell proliferation, colony formation, migration and invasion significantly, compared to the control miRNA. An miR-155 inhibitor was also used to evaluate whether miR-155 served as a therapeutic target for OS. The results demonstrated that the miR-155 inhibitor significantly reduced the proliferation, colony formation, migration and invasion of the MG-63 OS cells. Thus, the study confirmed the oncogenic regulation on the OS progression of miR-155, which could serve as a therapeutic target with an miR-155 inhibitor.
机译:骨肉瘤(OS)作为儿童时期最常见的恶性原发性骨肿瘤,尽管近几十年来高等级OS患者的总体生存率有了显着提高,但仍保持较高的复发率。因此,OS治疗需要新颖的治疗策略。近来,已经证实各种微RNA(miRNA或miR)在OS中被失调,并且通过微阵列分析发现了OS中的miR-155失调。在本研究中,在体外探索了miR-155对MG-63细胞上OS细胞增殖,迁移和侵袭的调控。与对照miRNA相比,发现miR-155模拟物显着促进细胞增殖,集落形成,迁移和侵袭。 miR-155抑制剂也用于评估miR-155是否充当OS的治疗靶标。结果表明,miR-155抑制剂显着降低了MG-63 OS细胞的增殖,集落形成,迁移和侵袭。因此,该研究证实了对miR-155 OS进程的致癌作用调节,该作用可与miR-155抑制剂一起用作治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号